Mastrangelo, S.; Rivetti, S.; Triarico, S.; Romano, A.; Attinà , G.; Maurizi, P.; Ruggiero, A.
Mechanisms, Characteristics, and Treatment of Neuropathic Pain and Peripheral Neuropathy Associated with Dinutuximab in Neuroblastoma Patients. Int. J. Mol. Sci. 2021, 22, 12648.
https://doi.org/10.3390/ijms222312648
AMA Style
Mastrangelo S, Rivetti S, Triarico S, Romano A, Attinà G, Maurizi P, Ruggiero A.
Mechanisms, Characteristics, and Treatment of Neuropathic Pain and Peripheral Neuropathy Associated with Dinutuximab in Neuroblastoma Patients. International Journal of Molecular Sciences. 2021; 22(23):12648.
https://doi.org/10.3390/ijms222312648
Chicago/Turabian Style
Mastrangelo, Stefano, Serena Rivetti, Silvia Triarico, Alberto Romano, Giorgio Attinà , Palma Maurizi, and Antonio Ruggiero.
2021. "Mechanisms, Characteristics, and Treatment of Neuropathic Pain and Peripheral Neuropathy Associated with Dinutuximab in Neuroblastoma Patients" International Journal of Molecular Sciences 22, no. 23: 12648.
https://doi.org/10.3390/ijms222312648
APA Style
Mastrangelo, S., Rivetti, S., Triarico, S., Romano, A., Attinà , G., Maurizi, P., & Ruggiero, A.
(2021). Mechanisms, Characteristics, and Treatment of Neuropathic Pain and Peripheral Neuropathy Associated with Dinutuximab in Neuroblastoma Patients. International Journal of Molecular Sciences, 22(23), 12648.
https://doi.org/10.3390/ijms222312648